Colorectal Cancer Whole Blood

<h2>Colorectal Cancer Whole Blood for Research</h2>
Colorectal cancer is commonly driven by APC, KRAS, and TP53 mutations, with CEA as a widely used circulating biomarker. Sanguine collects fresh whole blood from IRB-consented donors with a clinically confirmed colorectal cancer diagnosis for oncology genomics and biomarker research.
<h3>Product Features</h3>
<ul><li>Fresh whole blood from clinically diagnosed colorectal cancer donors</li><li>Custom anticoagulants and collection tubes available</li><li>Same-day collection and shipment</li><li>Research Use Only (RUO)</li></ul>
<h3>De-identified Donor Data</h3>
<ul><li>Physician-confirmed colorectal cancer diagnosis and stage where available</li><li>Demographics: age, sex assigned at birth, ethnicity</li><li>Relevant medical and treatment history</li></ul>
<h3>Applications</h3>
<ul><li>APC/KRAS/TP53 mutation analysis</li><li>CEA and circulating tumor biomarker studies</li><li>Gene expression and transcriptomic analysis</li><li>Chemotherapy response research</li></ul>
<h3>Also Available</h3>
Colorectal cancer samples are also available as leukopak for cell-based immune assays – contact us to discuss the right specimen type for your study.
<h3>Compliance and Quality</h3>
<ul><li>IRB-approved protocols and electronic informed consent</li><li>HIPAA-compliant donor data handling</li></ul>
<h3>Ordering and Customization</h3>
Colorectal cancer whole blood is available in standard and custom volumes. Email <a href=”mailto:learnmore@sanguinebio.com”>learnmore@sanguinebio.com</a> for international orders or documentation requirements.